Your Unread Messages in EndocrinologySee All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Board Exam Prep
2015 Endocrinology Board Exam Prep Course is Open. Take advantage of 100 new and challenging questions just added to the course. Prep Now!
NEWS The Washington Report
Is diet or exercise the best way to reduce diabetes risk?
1 Comparison of benazepril and losartan on endothelial function and vascular stiffness in patients with Type 2 diabetes mellitus and hypertension: A randomized controlled trial Journal of the Renin-Angiotensin-Aldosterone System, April 7, 2015
2 Diabetes drug shown not to increase heart failure risk University of Connecticut Health News, March 13, 2015
3 Replacing insulin glargine with neutral protamine hagedorn (NPH) insulin in a subpopulation of study subjects in the Action to Control Cardiovascular Risk in Diabetes (ACCORD): Effects on blood glucose levels, hypoglycemia and patient satisfaction Canadian Journal of Diabetes, March 26, 2015
4 Two treatment approaches for human regular U-500 insulin in patients with type 2 diabetes not achieving adequate glycemic control on high-dose U-100 insulin therapy with or without oral agents: a randomized, titration-to-target clinical trial Endocrine Practice, March 27, 2015
5 Treatment escalation options for patients with type 2 diabetes after failure of exenatide BID or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) Study Diabetes, Obesity and Metabolism, April 2, 2015
6 Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): A randomized controlled trial Diabetes Care, April 17, 2015
7 Frequency of self-monitoring blood glucose and attainment of HbA1c target values Acta Diabetologica, April 6, 2015
8 Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction Arteriosclerosis, Thrombosis, and Vascular Biology, April 1, 2015
9 Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort Diabetologia - Clinical and Experimental Diabetes and Metabolism, April 13, 2015
10 Contrasting effects of lixisenatide and liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: a randomized, open-label trial Diabetes Care, April 20, 2015
2015 © M3 USA. ALL Rights Reserved.